|ANI Pharmaceuticals Inc -- USA Stock|| |
USD 69.74 0.2 0.29%
VP of Operations
Mr. James G. Marken is Vice President Operations of the Company. He has served as the Companys Vice President, Operations, since June 2013 and was promoted to Senior Vice President, Operations and Product Development in May 2016. Mr. Marken joined ANIP in March 2007 as General Manager of the Minnesota facilities. As Vice President, Operations and Product Development, Mr. Marken was principally responsible for the following areas manufacturing, packaging, engineeringmaintenance, purchasing, and warehousing. Mr. Marken brings over 20 years of pharmaceutical industry experience to the Company. Prior to joining ANIP in March 2007, he worked for Solvay Pharmaceuticals as plant manager and in various departments including quality control, validation and manufacturing
Age: 53 VP Since 2013
Marken holds a B.S. degree in Chemistry from Bemidji State University.
The company has return on total asset (ROA)
of 7.09 %
which means that it generated profit of $7.09 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE)
of 4.25 %
meaning that it created $4.25 on every $100 dollars invested by stockholders.
The company currently holds 151.28 M in liabilities with Debt to Equity (D/E) ratio of 82.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. ANI Pharmaceuticals Inc has Current Ratio of 3.38 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.
ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States. ANI Pharmaceuticals Inc (ANIP) is traded on NASDAQ General Markets in USA. It is located in MINNESOTA, U.S.A and employs 108 people. ANI Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.